moderna

Health & Safety

Moderna's Vaccine Trial Sites, Including Wake Forest Baptist, Continue Study

4:50pm November 17, 2020

Data on the effectiveness of the Moderna vaccine looks promising, but the trial will continue for months to come. Some of that research is happening at Wake Forest Baptist Health in Winston-Salem.

The Pfizer COVID-19 vaccine needs to be stored at minus 70 Celsius. Health care providers will need to store it either in dry ice for shorter stints or in specialized freezers.

Health & Safety

Why Does Pfizer's COVID-19 Vaccine Need To Be Kept Colder Than Antarctica?

11:53am November 17, 2020

by Selena Simmons-Duffin

One of the two leading vaccine candidates requires deep, deep freezing. Here's how communities are working to solve for this and how the new Moderna vaccine could help.

Queue Listen Now

Clinical data for Moderna's COVID-19 vaccine showed it was nearly 95% effective in preventing disease, according to an interim analysis described in a company release Monday.

Health & Safety

Moderna's COVID-19 Vaccine Shines In Clinical Trial

10:21am November 16, 2020

by Joe Palca

The vaccine is nearly 95% effective in preventing illness, according to an interim analysis of a clinical test involving 30,000 people.

Queue Listen Now

A scientist at work on a COVID-19 vaccine candidate at Bogazici University in Istanbul in August.

How Can You Tell If A COVID-19 Vaccine Is Working?

1:21pm September 07, 2020

by Joe Palca

Several COVID-19 vaccine candidates are being tested now. But why does it take 30,000 volunteers to know if one is safe and effective? And what does it mean to say a vaccine candidate is working?

Queue Listen Now

Moderna, based in Cambridge, Mass., has reached phase three trials for its coronavirus vaccine. At the same time, its executives have sold tens of millions of dollars worth of stock, which has led to intense criticism of the company.

'Bad Optics' Or Something More? Moderna Executives' Stock Sales Raise Concerns

11:35am September 04, 2020

by Tom Dreisbach

Moderna is currently developing a promising, yet still unproven, vaccine against the coronavirus. But Moderna executives have already sold tens of millions of dollars worth of stock in the company.

A scientist works in a lab at Moderna in Cambridge, Mass., in February. Moderna has developed an experimental coronavirus medicine, but an approved treatment could be more than a year away.

HHS To Help Companies Develop COVID-19 Vaccines

4:15pm March 31, 2020

by Sydney Lupkin

The Department of Health and Human Services outlines support for Moderna and Johnson & Johnson, as the companies work to develop coronavirus vaccines. Beefing up manufacturing capacity is a priority.